×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
JNJ – johnson & johnson (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
JNJ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/13
04:18 pm
jnj
Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
Low
Report
Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
2/13
02:49 pm
jnj
Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial [Yahoo! Finance Canada]
Low
Report
Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial [Yahoo! Finance Canada]
2/13
02:48 pm
jnj
Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial [Yahoo! Finance]
Low
Report
Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial [Yahoo! Finance]
2/13
10:28 am
jnj
Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study [Yahoo! Finance]
Low
Report
Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study [Yahoo! Finance]
2/11
04:13 pm
jnj
TrumpRx is here and it helps, though a bit less than advertised [Fortune]
Low
Report
TrumpRx is here and it helps, though a bit less than advertised [Fortune]
2/10
10:33 pm
jnj
Is Johnson & Johnson a Buy, Sell, or Hold in 2026? [Yahoo! Finance]
Low
Report
Is Johnson & Johnson a Buy, Sell, or Hold in 2026? [Yahoo! Finance]
2/10
08:50 am
jnj
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market [Globe and Mail, The (Toronto, Canada)]
Low
Report
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market [Globe and Mail, The (Toronto, Canada)]
2/10
07:23 am
jnj
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now [Yahoo! Finance]
Low
Report
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/13
04:24 pm
jnj
Form 13F-HR JOHNSON & JOHNSON For: Dec 31
Low
Report
Form 13F-HR JOHNSON & JOHNSON For: Dec 31
2/13
02:34 pm
jnj
Form 144 JOHNSON & JOHNSON Filed by: Swanson James D.
Neutral
Report
Form 144 JOHNSON & JOHNSON Filed by: Swanson James D.
2/11
08:47 pm
jnj
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Wolk Joseph J
Low
Report
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Wolk Joseph J
2/11
08:46 pm
jnj
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Taubert Jennifer L
Low
Report
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Taubert Jennifer L
2/11
08:43 pm
jnj
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Swanson James D.
Low
Report
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Swanson James D.
2/11
08:41 pm
jnj
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Schmid Timothy
Low
Report
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Schmid Timothy
2/11
08:39 pm
jnj
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Mulholland Kristen
Low
Report
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Mulholland Kristen
2/11
08:37 pm
jnj
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Forminard Elizabeth
Low
Report
Form 4 JOHNSON & JOHNSON For: Feb 09 Filed by: Forminard Elizabeth
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/27
Form DEFA14A JOHNSON & JOHNSON
8.1%
3/12 Paul Harris' Top Picks: March 12, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 7.5%
4/7 Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? [Investor's Business Daily] 4.6%
4/5 Will These 3 Coronavirus Stocks Lead the Market to Recovery? [Yahoo! Finance News] 4.3%
4/13 Stocks slip as market enters new phase, with investors worrying about balance sheets [CNBC] 4.0%
3/2 AODocs Joins AIIM Leadership Council, Showcases Innovative Approach to Information Management at 2020 AIIM Conference 3.9%
3/4 Johnson & Johnson ordered to pay $1.7 million to three Australian women in pelvic mesh class action [Reuters] 3.8%
3/18 Is This 1 Healthcare Stock Coronavirus-Proof? [The Motley Fool] 3.8%
3/24 What Technology And Manufacturing Can Do To Help Against COVID-19 [Forbes] 3.6%
4/1 5 of the Best Stocks to Buy for April [Yahoo! Finance News] 3.3%
3/12 Paul Harris' Top Picks: March 12, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 7.5%
4/7 Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? [Investor's Business Daily] 4.6%
4/5 Will These 3 Coronavirus Stocks Lead the Market to Recovery? [Yahoo! Finance News] 4.3%
4/13 Stocks slip as market enters new phase, with investors worrying about balance sheets [CNBC] 4.0%
3/2 AODocs Joins AIIM Leadership Council, Showcases Innovative Approach to Information Management at 2020 AIIM Conference 3.9%
3/4 Johnson & Johnson ordered to pay $1.7 million to three Australian women in pelvic mesh class action [Reuters] 3.8%
3/18 Is This 1 Healthcare Stock Coronavirus-Proof? [The Motley Fool] 3.8%
3/24 What Technology And Manufacturing Can Do To Help Against COVID-19 [Forbes] 3.6%
4/1 5 of the Best Stocks to Buy for April [Yahoo! Finance News] 3.3%
TOP News Decliners
3/21
Johnson and Johnson: A Safe Haven in Recession [The Motley Fool]
-7.3%
3/20 Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? [Yahoo! Finance News] -6.9%
3/10 J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha] -6.8%
3/18 J&J files U.S. application for MS med ponesimod [Seeking Alpha] -6.6%
10/18 Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans Now [Forbes] -6.4%
5/28 Oklahoma taking on Johnson & Johnson in historic trial [MSNBC.com] -6.1%
3/13 Americans rush to stock up on essentials as coronavirus spreads [Reuters] -5.5%
3/11 Desperate to exit, a $10B price tag for Magic Leap is crazy [TechCrunch Blog] -4.9%
7/12 Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $156.00 price target on the stock. -4.5%
3/6 Eyecare industry leaders sign Proclamation to focus on key issues facing the future of optometry -3.8%
3/20 Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? [Yahoo! Finance News] -6.9%
3/10 J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha] -6.8%
3/18 J&J files U.S. application for MS med ponesimod [Seeking Alpha] -6.6%
10/18 Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans Now [Forbes] -6.4%
5/28 Oklahoma taking on Johnson & Johnson in historic trial [MSNBC.com] -6.1%
3/13 Americans rush to stock up on essentials as coronavirus spreads [Reuters] -5.5%
3/11 Desperate to exit, a $10B price tag for Magic Leap is crazy [TechCrunch Blog] -4.9%
7/12 Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $156.00 price target on the stock. -4.5%
3/6 Eyecare industry leaders sign Proclamation to focus on key issues facing the future of optometry -3.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: